NCT02656342View on ClinicalTrials.gov

Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients?

PHASE4CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

September 30, 2018

Study Completion Date

February 28, 2019

Conditions
Obsessive-Compulsive Disorder
Interventions
DRUG

D-Cycloserine

Predicted to enhance stabilization of the effects of concentrated exposure treatment

DRUG

Placebo

Predicted to have no enhancing effect

Trial Locations (14)

1300

Vestre Viken, Sandvika

1478

Akershus University Hospital, Lorenskog

1635

Østfold Hospital, Moss

2380

Innlandet Hospital, Brumunddal

3103

Sykehuset i Vestfold, Tønsberg

4604

Sørlandet Hospital, Kristiansand

5021

Haukeland University Hospital, Bergen

6812

Forde Hospital, Førde

7006

St. Olavs Hospital, Trondheim

7601

Nord Trøndelag Hospital, Levanger

Unknown

More and Romsdal Hospital, Molde

Stavanger University Hospital, Stavanger

Tromso University Hospital, Tromsø

0424

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

collaborator

Helse Vest

OTHER

lead

Haukeland University Hospital

OTHER

NCT02656342 - Translational Approach to the Understanding and Treatment of Obsessive-Compulsive Disorder (OCD). Can D-Cycloserine Enhance and Stabilize the Treatment-response in Relapsed and Non-responding OCD-patients? | Biotech Hunter | Biotech Hunter